Evidence map›Paper›PMID 35535099›Full record

ArticleJournal of clinical and experimental hepatology

Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis.

Chandrashekaraiah Bharath Kumar, Ashish Goel, Rajeeb Jaleel, Deepu David, Uday Zachariah, Jeyamani Ramachandran, Chundamannil E Eapen

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Cryptogenic chronic hepatitis: looking for an ideal diagnostic algorithm.Frontiers in gastroenterology (Lausanne, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chandrashekaraiah Bharath KumarDepartment of Gastroenterology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Ashish GoelDepartment of Hepatology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Rajeeb JaleelDepartment of Gastroenterology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Deepu DavidDepartment of Gastroenterology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Uday ZachariahDepartment of Hepatology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Jeyamani RamachandranDepartment of Hepatology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Chundamannil E EapenDepartment of Hepatology, Division of GI Sciences, CMC Hospital, Vellore, Tamil Nadu, India.
Government Vellore Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim of the study: To study the prevalence of risk factors for nonalcoholic fatty liver disease (NAFLD) in middle-aged (40-59 years) and elderly patients (≥60 years) with cryptogenic cirrhosis as compared to those with hepatitis B or C virus (HBV or HCV) related cirrhosis. Methods and materials: Between August 2013 and December 2014, cases (cryptogenic cirrhosis) and controls (HBV/HCV cirrhosis) above 40 years of age were prospectively recruited and assessed for the cause and prevalence of risk factors for NAFLD. Results: One hundred eighteen cases (male-74%; age 55 (40-74) years; median (range); Child's class A:B:C-46:38:16) and 59 controls (male-80%; age 55.5 (40-69) years; Child's class A:B:C-56:30:14) were enrolled. Obesity (53% v/s 39%, Conclusion: Among middle-aged and elderly patients with cirrhosis, there was a higher prevalence of risk factors for NAFLD in those with cryptogenic cirrhosis, compared to those with HBV or HCV cirrhosis.

Indexed as

BMI, Body Mass indexcryptogenic cirrhosisDM, Diabetes MellitusHBV or HCV, Hepatitis B or C virusHCC, Hepatocellular carcinomahepatitis B cirrhosishepatitis C cirrhosisMELD, Model for end stage liver diseaseNAFLD, Non Alcoholic Fatty Liver DiseaseNASH, Non-alcoholic steatohepatitisNCIPH, non cirrhotic intrahepatic portal hypertensionnonalcoholic fatty liver diseaserisk factors of NAFLDWHR, Waist hip ratio

Identifiers

PMID35535099
PMCPMC9077180
OpenAlexW3168831212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.